CN110229857A - The preparation method of bird's nest peptide and its depolymerization coupled enzymatic - Google Patents
The preparation method of bird's nest peptide and its depolymerization coupled enzymatic Download PDFInfo
- Publication number
- CN110229857A CN110229857A CN201910406255.0A CN201910406255A CN110229857A CN 110229857 A CN110229857 A CN 110229857A CN 201910406255 A CN201910406255 A CN 201910406255A CN 110229857 A CN110229857 A CN 110229857A
- Authority
- CN
- China
- Prior art keywords
- bird
- nest
- peptide
- enzyme
- nest peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 244000000626 Daucus carota Species 0.000 title claims abstract description 158
- 235000005770 birds nest Nutrition 0.000 title claims abstract description 158
- 235000005765 wild carrot Nutrition 0.000 title claims abstract description 158
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 112
- 230000002255 enzymatic effect Effects 0.000 title claims abstract description 7
- 238000002360 preparation method Methods 0.000 title claims description 43
- 238000000034 method Methods 0.000 claims abstract description 51
- 239000004365 Protease Substances 0.000 claims abstract description 28
- 102000004190 Enzymes Human genes 0.000 claims abstract description 24
- 108090000790 Enzymes Proteins 0.000 claims abstract description 24
- 108091005804 Peptidases Proteins 0.000 claims abstract description 22
- 238000001914 filtration Methods 0.000 claims abstract description 16
- 230000009849 deactivation Effects 0.000 claims abstract description 11
- 239000003814 drug Substances 0.000 claims abstract description 11
- 238000004925 denaturation Methods 0.000 claims abstract description 10
- 230000036425 denaturation Effects 0.000 claims abstract description 10
- 235000013402 health food Nutrition 0.000 claims abstract description 10
- 229940079593 drug Drugs 0.000 claims abstract description 9
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract 5
- 229940088598 enzyme Drugs 0.000 claims description 24
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 102000035195 Peptidases Human genes 0.000 claims description 17
- 235000019419 proteases Nutrition 0.000 claims description 14
- 108090000526 Papain Proteins 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 235000019834 papain Nutrition 0.000 claims description 10
- 229940055729 papain Drugs 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 7
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 7
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 7
- 239000003513 alkali Substances 0.000 claims description 6
- 238000007654 immersion Methods 0.000 claims description 6
- 230000036039 immunity Effects 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 108010004032 Bromelains Proteins 0.000 claims description 3
- 102000057297 Pepsin A Human genes 0.000 claims description 3
- 108090000284 Pepsin A Proteins 0.000 claims description 3
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 claims description 3
- 235000019835 bromelain Nutrition 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 229940111202 pepsin Drugs 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 11
- 210000002540 macrophage Anatomy 0.000 description 10
- 210000001541 thymus gland Anatomy 0.000 description 10
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 9
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 206010057249 Phagocytosis Diseases 0.000 description 7
- 210000000683 abdominal cavity Anatomy 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 230000008782 phagocytosis Effects 0.000 description 7
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000001771 impaired effect Effects 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 230000000242 pagocytic effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 108010038807 Oligopeptides Proteins 0.000 description 3
- 102000015636 Oligopeptides Human genes 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 229960000890 hydrocortisone Drugs 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 2
- 102000007079 Peptide Fragments Human genes 0.000 description 2
- 108010033276 Peptide Fragments Proteins 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000005352 clarification Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000272876 Apodidae Species 0.000 description 1
- 241000272878 Apodiformes Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000011950 custard Nutrition 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- -1 tincture Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention provides the methods that depolymerization coupled enzymatic prepares bird's nest peptide to crush the bird's nest after denaturation including being denaturalized to the bird's nest impregnated, smashed bird's nest is adjusted into pH to 6.5-7.5, protease is then added, is digested, to enzymolysis product enzyme deactivation, filtering.The bird's nest peptide prepared the present invention also provides this method and its application in drug or health food etc..
Description
Technical field
The invention belongs to protein and peptide technical fields, specifically, the present invention relates to be related to the depolymerization coupling of bird's nest albumen
The bird's nest peptide for closing enzymolysis preparation and its preparing.
Background technique
Bird's nest (Edible bird's nest, EBN) refers to that a variety of esculent swifts of Apodidae are solidifying with saliva and a small amount of down etc.
Tie built nest.Bird's nest is a kind of rare tonic, has nourishing yin to moisten dryness, tonifying middle-Jiao and Qi, enters the function such as stomach tonifying spleen, preventing phlegm from forming and stopping coughing
Can, it is known as " first of eight delicacies ".Chinese medicine thinks bird's nest: nourishing yin to moisten dryness, invigorating middle warmer and replenishing QI, governance wasting, expectoration asthma, hemoptysis, protracted dysentery are fitted
It is suitable for and has a delicate constitution, malnutritive, protracted dysentery chronic malaria, many coughs of phlegm, senile chronic bronchitis, bronchiectasis, pulmonary emphysema, lung
Tuberculosis, hemoptysis are spitted blood and stomachache patients.Modern medicine discovery, bird's nest can promote immune function, there is delaying human body caducity, prolong
The effect of year lengthens one's life.The study found that bird's nest main component has: water soluble protein, carbohydrate, microelement (including calcium,
Phosphorus, iron, sodium, potassium) and to the amino acid for promoting human activity to play an important role, wherein protein content is 60% or so.
Currently, the peptides product of some bird's nests is reported.For example, Chinese patent application CN107974479A is disclosed
A kind of method that bird's nest oligopeptide is prepared with microwave and membrane technology, comprising: first bird's nest is crushed, is impregnated with hot deionized water swollen
Hair, is starched with colloid mill circular grinding at bird's nest, adds deionized water, is adjusted pH value to 10.6, is flowed out protein with microwave treatment,
Assemble bird's nest oligopeptide in microwave-assisted lower carry out double-enzyme hydrolysis, then through ultrafiltration and nanofiltration.The peptide fragment of the oligopeptide is distributed in 5
- 16 peptide of peptide, the relative molecular weight of peptide are 539-1745Da.
For another example, Chinese patent application CN108070018A discloses a kind of method that bird's nest native peptides are extracted from bird's nest,
This method obtains the optimum condition for extracting bird's nest native peptides by screening test, is the pH value of 9.5, termination including initial pH value
It is≤8.4 etc..The peptide fragment for the bird's nest native peptides that this method is extracted is from 5 peptides to 19 peptides.
Also such as, Chinese patent application CN108893511A discloses a kind of method that bird's nest extracts small-molecular peptides, comprising: uses
Clear water impregnates bird's nest and drying；Bird's nest after drying is crushed, screening；Powder after screening is subjected to broken wall, obtains fine powder；To
Fine powder adds deionized water, is digested using zytase, pectase, papain complex gradient, then through papain
Protein is digested.
In addition, Chinese patent application CN107488225A discloses a kind of method that bird's nest extracts small-molecular peptides, comprising: will
Bird's nest is dried by the sun, is ground into powder, and in the powder plus deionized water is modulated into mixed liquor, and mixed liquor is put into ultrasonic water
Electromagnetic heating enzymatic hydrolysis is carried out after vibrating in bath under alkaline environment, with the centrifuge for the centrifugal drum for being mounted with 3 layers of filter membrane of band
Separation mixed liquor obtains refined filtration liquid, and the refined filtration liquid is placed in the cold low-temperature stabilization of icebox, refined filtration liquid is moved to vacuum drier
The small-molecular peptides that the bird's nest extracts are obtained after drying, improve human body to the absorbability of bird's nest small-molecular peptides.
The method of the peptides product of these prior art preparation bird's nests, what is had is cumbersome, and equipment investment is big, and what is had is simple and crude, produces
Rate is low, in addition to this, more seriously, although mostly brag about will be in bird's nest for the peptides product of the bird's nest of these technologies preparation
Breaks down proteins be the small-molecular peptides easily absorbed, improve the bioavailability of bird's nest, but they are actual medicinal or protect
Strong effect is inaccurate, it is difficult to practical to promote the use of.
The present inventor relies on long-term further investigation, has investigated a kind of depolymerization coupled enzymatic system to bird's nest unexpectedly
The method of standby bird's nest peptide, not only method is easy to operate, and equipment investment is little, and the new bird's nest peptide prepared with this method in addition to
Have the characteristics that small-molecular peptides easily absorb, and it is medicinal, health-care effect is definite, immunity can be significantly improved.
Summary of the invention
It is medicinal, health-care effect is definite the technical problem to be solved in the present invention is that provide new bird's nest peptide, better than tradition
The bird's nest product of technology preparation.In addition, improving the present invention also provides the preparation method of the bird's nest peptide and such as immunity side
The application in face etc..
Specifically, in a first aspect, coupling enzyme by the depolymerization included the following steps the present invention provides bird's nest peptide
Solve preparation method preparation:
(1) clean bird's nest is taken, is soaked in water；
(2) bird's nest impregnated is denaturalized；
(3) bird's nest after denaturation is crushed；
(4) smashed bird's nest is adjusted into pH to 6.5-7.5, protease is then added, is digested；
(5) to enzymolysis product enzyme deactivation, filtering；With
(6) optionally the enzymolysis liquid of filtering is concentrated, dried.
It is preferred that the weight ratio of bird's nest and water is 1:40- in the preparation step (1) of the bird's nest peptide of first aspect present invention
80, preferably 1:50-70, such as 1:60.
It is also preferred that the temperature of immersion is 15-30 DEG C, excellent in the preparation step (1) of the bird's nest peptide of first aspect present invention
It is selected as 22-26 DEG C, such as room temperature.In general, room temperature can be 25 DEG C.
Further preferably in the preparation step (1) of the bird's nest peptide of first aspect present invention, the time of immersion is 2-6 hours, excellent
It is selected as 3-5 hours, such as 4 hours.
The method being denaturalized in the preparation step (2) of the bird's nest peptide of first aspect present invention can be physical method, such as heating,
Pressurization, dehydration, stirring, oscillation, ultraviolet light irradiation and/or ultrasonication etc., are also possible to chemical method, such as with strong acid, strong
Alkali, urea, heavy metallic salt and/or lauryl sodium sulfate (SDS) etc. processing etc., can also be it is above-mentioned either physically or chemically in
Two or more combination.In a specific embodiment of the invention, denaturation is heat denatured.
It is preferred that the temperature of heating is 90-100 DEG C, preferably in the preparation step (2) of the bird's nest peptide of first aspect present invention
It is 95-100 DEG C, such as 100 DEG C.
It is also preferred that the time of heating is 30-60 minutes in the preparation step (2) of the bird's nest peptide of first aspect present invention,
Preferably 35-50 minutes, such as 40 minutes.
The method crushed in the preparation step (3) of the bird's nest peptide of first aspect present invention can be ultramicro grinding, colloid mill
It crushes, broken wall crushes, ball mill crushes, one or several kinds of combinations of homogenizer homogeneous and/or high pressure homogenizer.In this hair
In bright specific embodiment, crushing is homogenate.
It is preferred that adjusting the reagent of pH in the preparation step (4) of the bird's nest peptide of first aspect present invention as acid, preferably vinegar
Acid.
It is also preferred that protease is pepsin, tryptose in the preparation step (4) of the bird's nest peptide of first aspect present invention
Enzyme, animal proteolytic enzyme, neutral proteinase, papain, bromelain, alkali protease, stromatin enzyme, flavor
One of enzyme or two or more combinations.In a specific embodiment of the invention, protease is animal proteolytic enzyme
And/or papain.
Further preferably in the preparation step (4) of the bird's nest peptide of first aspect present invention, the temperature of enzymatic hydrolysis is 25-60 DEG C, excellent
It is selected as 30-55 DEG C, such as 50 DEG C.
In addition preferably in the preparation step (4) of the bird's nest peptide of first aspect present invention, the time of enzymatic hydrolysis is 1-6 hours,
Preferably 2-5 hours, such as 3 hours.
It is preferred that the temperature of enzyme deactivation is 80-100 DEG C, preferably in the preparation step (5) of the bird's nest peptide of first aspect present invention
It is 85-98 DEG C, such as 95 DEG C.
It is also preferred that the time of enzyme deactivation is 15-60 minutes in the preparation step (5) of the bird's nest peptide of first aspect present invention,
Preferably 20-45 minutes, such as 30 minutes.
Further preferably in the preparation step (5) of the bird's nest peptide of first aspect present invention, the membrane aperture of filtering is 150-200
Mesh, preferably 180-200 mesh, such as 200 mesh.
Herein, it optionally indicates it can be selected that can not also select.That is, the system of the bird's nest peptide of first aspect present invention
Standby step (6) can be not selected progress, then the bird's nest peptide of first aspect present invention exists in solution；Also it can choose
The step (6) is carried out, so that the bird's nest peptide of first aspect present invention exists in solid form.
The molecular particle size of the bird's nest peptide of first aspect present invention is small, is uniformly dispersed, and predominantly contains 2-20 amino acid
The polypeptide of residue.It is preferred that the content of small-molecular peptides of the molecular weight of the bird's nest peptide of first aspect present invention between 200-2500Da
For 70-90% (w/w), preferably 80-90% (w/w), for example 86-88% (w/w).
In second aspect, the present invention provides pharmaceutical compositions comprising the bird's nest peptide and pharmacy of first aspect present invention
Upper acceptable auxiliary material.In a specific embodiment of the invention, the pharmaceutical composition of second aspect of the present invention can be used for restoring
Impaired immune organ improves abdominal cavity macrophage phagocytosis.
Herein, term " pharmaceutically acceptable auxiliary material " includes pharmaceutically acceptable carrier, excipient, diluent
Deng they are compatible with active pharmaceutical ingredient.Pharmaceutical preparation is prepared to ordinary skill with pharmaceutically acceptable auxiliary material
It is well known for personnel.Pharmaceutical composition of the invention includes the bird's nest peptide of first aspect present invention as active constituent, will
The bird's nest peptide and pharmaceutically acceptable adjuvant (carrier, excipient, diluent as would be known to one of ordinary skill in the art
Deng) combine, various preparations, preferably solid pharmaceutical preparation and liquid preparation are configured to, as tablet, pill, capsule (including are held
Releasing pattern is released in continuous release or delay), pulvis, suspension, granule, tincture, syrup, emulsion agent, the dosage forms such as suspension with
And various sustained-release dosage types, to be suitble to various form of medication, such as form of medication oral or by skin etc., most preferably mouth
Clothes.
In the third aspect, the present invention provides health-care food compositions comprising the bird's nest peptide of first aspect present invention and
Acceptable auxiliary material in health food.In a specific embodiment of the invention, the health food combination of third aspect present invention
Object can be used for restoring impaired immune organ, improve abdominal cavity macrophage phagocytosis.
Herein, term " acceptable auxiliary material in health food " include acceptable carrier on food, it is excipient, dilute
Agent, flavoring agent, colorant, fumet etc. are released, they are compatible with the healthcare active of health food.First aspect present invention
Bird's nest peptide can be directly added into food perhaps can for example add in raw-food material contain or soup without containing sweetener or
In custard.
In fourth aspect, the present invention provides the methods that depolymerization coupled enzymatic prepares bird's nest peptide comprising following steps:
(1) clean bird's nest is taken, is soaked in water；
(2) bird's nest impregnated is denaturalized；
(3) bird's nest after denaturation is crushed；
(4) smashed bird's nest is adjusted into pH to 6.5-7.5, protease is then added, is digested；
(5) to enzymolysis product enzyme deactivation, filtering；With
(6) optionally the enzymolysis liquid of filtering is concentrated, dried.
It is preferred that the weight ratio of bird's nest and water is 1:40-80, preferably the method for fourth aspect present invention the step of in (1)
For 1:50-70, such as 1:60.
It is also preferred that the temperature of immersion is 15-30 DEG C, preferably 22- the method for fourth aspect present invention the step of in (1)
26 DEG C, such as room temperature.In general, room temperature can be 25 DEG C.
Further preferably the method for fourth aspect present invention the step of in (1), the time of immersion is 2-6 hours, preferably 3-5
Hour, such as 4 hours.
The method being denaturalized in the step of method of fourth aspect present invention (2) can be physical method, such as heat, pressurize,
Dehydration, stirring, oscillation, ultraviolet light irradiation and/or ultrasonication etc., are also possible to chemical method, such as use strong acid, highly basic, urine
Processing such as element, heavy metallic salt and/or lauryl sodium sulfate (SDS) etc., can also be it is above-mentioned either physically or chemically in two kinds
Or two or more combination.In a specific embodiment of the invention, denaturation is heat denatured.
It is preferred that the temperature of heating is 90-100 DEG C, preferably 95- the method for fourth aspect present invention the step of in (2)
100 DEG C, such as 100 DEG C.
It is also preferred that the time of heating is 30-60 minutes, preferably the method for fourth aspect present invention the step of in (2)
35-50 minutes, such as 40 minutes.
The method crushed in the step of method of fourth aspect present invention (3) can be ultramicro grinding, colloid mill crushes, broken
Wall crushes, ball mill crushes, one or several kinds of combinations of homogenizer homogeneous and/or high pressure homogenizer.In tool of the invention
In body embodiment, crushing is homogenate.
It is preferred that adjusting the reagent of pH the method for fourth aspect present invention the step of in (4) as acid, preferably acetic acid.
It is also preferred that the method for fourth aspect present invention the step of in (4), protease is pepsin, trypsase, dynamic
Object proteolytic enzyme, neutral proteinase, papain, bromelain, alkali protease, stromatin enzyme, in food flavor enzyme
One or more kinds of combinations.In a specific embodiment of the invention, protease be animal proteolytic enzyme and/or
Papain.
Further preferably the method for fourth aspect present invention the step of in (4), the temperature of enzymatic hydrolysis is 25-60 DEG C, preferably 30-
55 DEG C, such as 50 DEG C.
In addition preferably the method for fourth aspect present invention the step of in (4), the time of enzymatic hydrolysis is 1-6 hours, preferably
2-5 hours, such as 3 hours.
It is preferred that the temperature of enzyme deactivation is 80-100 DEG C, preferably 85- the method for fourth aspect present invention the step of in (5)
98 DEG C, such as 95 DEG C.
It is also preferred that the time of enzyme deactivation is 15-60 minutes, preferably the method for fourth aspect present invention the step of in (5)
20-45 minutes, such as 30 minutes.
Further preferably the method for fourth aspect present invention the step of in (5), the membrane aperture of filtering is 150-200 mesh, preferably
For 180-200 mesh, such as 200 mesh.
At the 5th aspect, the present invention provides the bird's nest peptides of first aspect present invention to improve or restore immunity in preparation
Application in drug or health food.In a specific embodiment of the invention, the bird's nest peptide of first aspect present invention can be used for
Restore impaired immune organ, improve abdominal cavity macrophage phagocytosis, restores or the ability of raising is significantly better than and is made in the conventional way
Bird's nest product.
It is preferred that drug is the pharmaceutical composition of second aspect of the present invention in the application of fifth aspect present invention.
It is also preferred that health food is the health food combination of third aspect present invention in the application of fifth aspect present invention
Object.
The beneficial effects of the present invention are: provide new bird's nest peptide, it is medicinal, health-care effect is definite, it can significantly improve
Immunity, significant effect are better than the bird's nest product of conventional method preparation；The bird's nest peptide prepares bird's nest peptide using depolymerization coupled enzymatic
Method preparation, preparation method is easy to operate, and equipment investment is little.
In order to make it easy to understand, the present invention will be described in detail by specific embodiment below.It needs to refer in particular to
Out, these descriptions are only exemplary description, and are not meant to limit the scope of the invention.Opinion according to this specification
It states, many variations of the invention, change will be apparent from for those skilled in the art.
In addition, the present invention refers to open source literature, these documents are their full text in order to more clearly describe the present invention
Content is included in and is referred to herein, just looks like that repeated description herein has been excessively for their full text.
Specific embodiment
The contents of the present invention are further illustrated by the following examples.Such as not specified, technology used in embodiment
The conventional means and commercially available common instrument, reagent that means are well known to those skilled in the art, reference can be made to " Molecular Cloning: A Laboratory
Guide (the 3rd edition) " (Science Press), " Microbiology Experiment (the 4th edition) " (Higher Education Publishing House) and corresponding instrument and
The reference such as manufacturers instruction of reagent.
The illustrative preparation method 1 of 1 bird's nest peptide of embodiment
Dry bird's nest (the white swallow of Malaysia) 6.5g is weighed, 60 times of (relative to dry bird's nest) purifying are added after cleaning up
Water soaking at room temperature 4 hours.The bird's nest impregnated is placed in closed container together with water, is divided with heat denatured 40 in 100 DEG C of boiling water baths
Clock is subsequently cooled to 50 DEG C.By after denaturation bird's nest be packed into refiner (MA60 model is purchased from OuHor company) with 3000 turns/
Second homogeneous is homogenized 5 minutes.Dilute hydrochloric acid is added to the bird's nest of homogenate, adjusts pH to 7,13mg papain (200,000 is then added
U/g enzyme activity, is purchased from Pangbo Bioengineering Co Ltd, Nanning) and 13mg alkali protease (200,000 u/g enzyme activities, it is commercially available
From Pangbo Bioengineering Co Ltd, Nanning), in 50 DEG C constant-temperature table digestion 3 hours.Enzymolysis product is heated to 95 DEG C, is kept
30 minutes, enzyme is inactivated, then, crosses the removal of impurities of 200 mesh filter clothes, obtain clarification enzymolysis liquid.Finally, enzymolysis liquid is concentrated, it is freeze-dried
Obtain 6.1 grams of bird's nest Gly-His-Lys.
It is detected through GPC gel permeation chromatography, small molecule of the resulting bird's nest Gly-His-Lys middle-molecular-weihydroxyethyl between 200-2500Da
The content of peptide is 87%.
The illustrative preparation method 2 of 2 bird's nest peptide of embodiment
The method that preparation method is substantially identical to embodiment 1, except that with 13mg animal proteolytic enzyme (200,000 u/
G enzyme activity, is purchased from Pangbo Bioengineering Co Ltd, Nanning) replace papain to be digested.Finally obtain bird's nest peptide
6.0 grams of powder, through detecting, the content of small-molecular peptides of the resulting bird's nest Gly-His-Lys middle-molecular-weihydroxyethyl between 200-2500Da is 80%.
Bird's nest peptide preparation method of the comparative example 1 without crushing process
The method that preparation method is substantially identical to embodiment 1, except that the bird's nest after denaturation is not packed into refiner, and
It is directly to adjust pH after being cooled to 50 DEG C, adds papain enzymolysis and alkali protease, and carry out subsequent step.It finally obtains
6.0 grams of bird's nest Gly-His-Lys, through detecting, the content of small-molecular peptides of the resulting bird's nest Gly-His-Lys middle-molecular-weihydroxyethyl between 200-2500Da is
63%.
Bird's nest peptide preparation method of the comparative example 2 without degenerative process
The method that preparation method is substantially identical to embodiment 1, except that the bird's nest impregnated without denaturation, but
It is directly loadable into refiner homogenate, and carries out subsequent step.6.0 grams of bird's nest Gly-His-Lys are finally obtained, through detecting, resulting bird's nest Gly-His-Lys
The content of small-molecular peptides of the middle-molecular-weihydroxyethyl between 200-2500Da is 55%.
The traditional preparation methods of 3 bird's nest peptide of comparative example
Dry bird's nest 6.5g is weighed, it is small that 60 times of (relative to dry bird's nest) purified water soaking at room temperature 4 are added after cleaning up
When.The bird's nest impregnated is placed in closed container, is stewed 12 hours with 95 DEG C of high temperature, is then crossed 200 mesh filter clothes, obtain clarification filtration
Liquid.Finally, filtered fluid is concentrated, freeze-drying obtains 5.9 grams of bird's nest Gly-His-Lys.
It is detected through GPC gel permeation chromatography, small molecule of the resulting bird's nest Gly-His-Lys middle-molecular-weihydroxyethyl between 200-2500Da
The content of peptide is 43%.
Effect of the effect example bird's nest peptide to immune function of mice
Using the bird's nest peptide of according to embodiments of the present invention and comparative example preparation, to observe the effect to immune function of mice,
Specific experiment is as follows:
1, experimental method
70 kunming mices are taken, are randomly divided into following 7 groups, every group 10, the drug of the daily following each group of gastric infusion, often
It is primary, and each 0.1ml is carried out continuously 4 weeks:
(1) normal group: physiological saline
(2) model group: physiological saline
(3) bird's nest peptide group one: the bird's nest peptide of 1 preparation according to embodiments of the present invention, dosage 20mg/kg
(4) bird's nest peptide group two: the bird's nest peptide of 2 preparation according to embodiments of the present invention, dosage 20mg/kg
(5) bird's nest peptide group three: the bird's nest peptide that according to the present invention prepared by comparative example 1, dosage 20mg/kg
(6) bird's nest peptide group four: the bird's nest peptide that according to the present invention prepared by comparative example 2, dosage 20mg/kg
(7) bird's nest peptide group five: the bird's nest peptide that according to the present invention prepared by comparative example 3, dosage 20mg/kg.
In addition to Normal group, remaining each group mouse subcutaneous injection hydrocortisone on the 21st after first administration,
Dosage is 15mg/kg, once a day, is carried out continuously 6 days.After the last administration, mouse is deprived of food but not water 12 hours, every mouse abdomen
Chamber is weighed after injecting 2% chicken erythrocyte suspension 1mL, 30min, and then rear cervical dislocation is put to death, and removes spleen, thymus gland weighing respectively,
To calculate spleen index and thymus index；In addition peritoneal macrophage is collected, is dyed and is counted, phagocytic rate is calculated.
2, experimental result
The results are shown in Table 1 for the spleen index and thymus index of each group mouse, wherein the spleen index and thymus gland of model group refer to
Number is substantially less than normal group, shows that the ratio of immune organ and weight can be substantially reduced by continuously injecting hydrocortisone, be shown
Modeling success；Bird's nest peptide group five conventionally can slightly improve spleen index and thymus index, however relative to model group,
It is this to improve no conspicuousness；According to the bird's nest peptide group one and group two of the method for the present invention spleen can be significantly improved relative to model group
Index and thymus index；The bird's nest peptide group three and group four for cannoing be used up whole method improve the amplitude of spleen indexs and thymus index between
Conventionally and according between the method for the present invention, the thymus index of raising is significantly higher than model group, but spleen index mentions
Height does not have conspicuousness relative to model group.
Influence of each drug of table 1 to the spleen index and thymus index of mouse
| Group | Spleen index | Thymus index |
| Normal group | 4.43±0.41 | 1.53±0.37 |
| Model group | 3.11±0.30 | 1.15±0.28 |
| Bird's nest peptide group one | 3.80±0.33 | 1.91±0.31 |
| Bird's nest peptide group two | 3.72±0.36 | 1.85±0.22 |
| Bird's nest peptide group three | 3.57±0.52 | 1.69±0.29 |
| Bird's nest peptide group four | 3.64±0.55 | 1.72±0.25 |
| Bird's nest peptide group five | 3.42±0.46 | 1.59±0.39 |
The result shows that can significantly restore impaired immune organ according to bird's nest peptide prepared by the method for the present invention；Even if saving
Slightly a part of step of the method for the present invention, the bird's nest peptide of preparation also can significantly restore impaired partial immunity organ, restore width
Degree is prepared not as good as the method for the present invention；Although and the bird's nest peptide traditionally prepared can restore from mean value, group
On do not show and restore in the presence of significant.
The results are shown in Table 2 for the abdominal cavity macrophage phagocytosis of each group mouse, wherein the abdominal cavity macrophage phagocytosis of model group is aobvious
It writes and is lower than normal group, show that macrophages phagocytic capacity can be significantly reduced by continuously injecting hydrocortisone, show modeling success；Nothing
By whole method conventionally, is cannotd be used up, also according to the method for the present invention, prepared bird's nest peptide can be relative to model
Group significantly improves abdominal cavity macrophage phagocytosis, wherein mentioning according to the increase rate maximum of the method for the present invention, and conventionally
High-amplitude is minimum.
Influence of each drug of table 2 to the macrophages phagocytic capacity of mouse
| Group | Abdominal cavity macrophage phagocytosis (%) |
| Normal group | 33.6±5.1 |
| Model group | 24.3±4.7 |
| Bird's nest peptide group one | 42.5±3.9 |
| Bird's nest peptide group two | 40.8±2.8 |
| Bird's nest peptide group three | 36.4±3.5 |
| Bird's nest peptide group four | 37.5±5.3 |
| Bird's nest peptide group five | 33.4±4.4 |
The result shows that the bird's nest peptide prepared using various methods can significantly improve the macrophages phagocytic capacity of mouse,
Promote immune function, and it is best according to effect prepared by the method for the present invention.
Claims (10)
1. bird's nest peptide is prepared by the depolymerization coupled enzymatic preparation method included the following steps:
(1) clean bird's nest is taken, is soaked in water；
(2) bird's nest impregnated is denaturalized, preferably heat denatured；
(3) bird's nest after denaturation is crushed, is preferably homogenized；
(4) smashed bird's nest is adjusted into pH to 6.5-7.5, protease is then added, is digested；
(5) to enzymolysis product enzyme deactivation, filtering；With
(6) optionally the enzymolysis liquid of filtering is concentrated, dried.
2. bird's nest peptide described in claim 1, wherein
The weight ratio of bird's nest and water in step (1) is 1:40-80, preferably 1:50-70, such as 1:60；
The temperature of immersion in step (1) be 15-30 DEG C, preferably 22-26 DEG C, such as room temperature；And/or
The time of immersion in step (1) is 2-6 hours, preferably 3-5 hours, such as 4 hours.
3. bird's nest peptide described in claim 1, wherein
The temperature of heating in step (2) is 90-100 DEG C, preferably 95-100 DEG C, such as 100 DEG C；And/or
The time of heating in step (2) is 30-60 minutes, preferably 35-50 minutes, such as 40 minutes.
4. bird's nest peptide described in claim 1, wherein
The reagent of adjusting pH in step (4) is acid, preferably acetic acid；
Protease in step (4) is pepsin, trypsase, animal proteolytic enzyme, neutral proteinase, Papain
One of enzyme, bromelain, alkali protease, stromatin enzyme, food flavor enzyme or two or more combinations, it is preferably dynamic
Object proteolytic enzyme and/or papain；
The temperature of enzymatic hydrolysis in step (4) is 25-60 DEG C, preferably 30-55 DEG C, such as 50 DEG C；And/or
The time of enzymatic hydrolysis in step (4) is 1-6 hours, preferably 2-5 hours, such as 3 hours.
5. bird's nest peptide described in claim 1, wherein
The temperature of enzyme deactivation in step (5) is 80-100 DEG C, preferably 85-98 DEG C, such as 95 DEG C；
The time of enzyme deactivation in step (5) is 15-60 minutes, preferably 20-45 minutes, such as 30 minutes；And/or
The membrane aperture of filtering in step (5) is 150-200 mesh, preferably 180-200 mesh, such as 200 mesh.
6. bird's nest peptide described in claim 1, the content of small-molecular peptides of the middle-molecular-weihydroxyethyl between 200-2500Da is 70-
90% (w/w), preferably 80-90% (w/w), for example 86-88% (w/w).
7. pharmaceutical composition comprising any the bird's nest peptide and pharmaceutically acceptable auxiliary material of claim 1-6.
8. health-care food composition comprising acceptable in any the bird's nest peptide and health food of claim 1-6
Auxiliary material.
9. the method that depolymerization coupled enzymatic prepares bird's nest peptide comprising following steps:
(1) clean bird's nest is taken, is soaked in water；
(2) bird's nest impregnated is denaturalized, preferably heat denatured；
(3) bird's nest after denaturation is crushed, is preferably homogenized；
(4) smashed bird's nest is adjusted into pH to 6.5-7.5, protease is then added, is digested；
(5) to enzymolysis product enzyme deactivation, filtering；With
(6) optionally the enzymolysis liquid of filtering is concentrated, dried.
10. any bird's nest peptide of claim 1-6 improves in preparation or restores in the drug or health food of immunity
Application.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910406255.0A CN110229857B (en) | 2019-05-16 | 2019-05-16 | Bird's nest peptide and preparation method of depolymerized coupling enzymolysis thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910406255.0A CN110229857B (en) | 2019-05-16 | 2019-05-16 | Bird's nest peptide and preparation method of depolymerized coupling enzymolysis thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110229857A true CN110229857A (en) | 2019-09-13 |
| CN110229857B CN110229857B (en) | 2021-04-13 |
Family
ID=67860738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910406255.0A Active CN110229857B (en) | 2019-05-16 | 2019-05-16 | Bird's nest peptide and preparation method of depolymerized coupling enzymolysis thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110229857B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111406826A (en) * | 2020-04-30 | 2020-07-14 | 湖北瑞邦生物科技有限公司 | Production method of cubilose peptide product and filtering structure used in production |
| CN113974156A (en) * | 2021-11-23 | 2022-01-28 | 厦门市燕之屋丝浓食品有限公司 | Edible bird's nest oral instant film and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003095961A (en) * | 2001-09-27 | 2003-04-03 | Combi Corp | Skin beautifying promoter |
| CN102102119A (en) * | 2010-12-03 | 2011-06-22 | 北京中生奥普寡肽技术研究所 | Bird's nest oligopeptide composition and preparation method and use thereof |
| CN103436579A (en) * | 2013-08-01 | 2013-12-11 | 香港科技大学 | Method for preparing cubilose extract with strong antioxidation |
| JP2015133943A (en) * | 2014-01-17 | 2015-07-27 | 金利食安科技股▲ふん▼有限公司 | Swallow nest extraction method using pressure and enzyme in combination |
| CN107488225A (en) * | 2017-10-20 | 2017-12-19 | 广西佛斯肽生物科技有限公司 | A kind of method of bird's nest extraction small-molecular peptides |
-
2019
- 2019-05-16 CN CN201910406255.0A patent/CN110229857B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003095961A (en) * | 2001-09-27 | 2003-04-03 | Combi Corp | Skin beautifying promoter |
| CN102102119A (en) * | 2010-12-03 | 2011-06-22 | 北京中生奥普寡肽技术研究所 | Bird's nest oligopeptide composition and preparation method and use thereof |
| CN103436579A (en) * | 2013-08-01 | 2013-12-11 | 香港科技大学 | Method for preparing cubilose extract with strong antioxidation |
| JP2015133943A (en) * | 2014-01-17 | 2015-07-27 | 金利食安科技股▲ふん▼有限公司 | Swallow nest extraction method using pressure and enzyme in combination |
| CN107488225A (en) * | 2017-10-20 | 2017-12-19 | 广西佛斯肽生物科技有限公司 | A kind of method of bird's nest extraction small-molecular peptides |
Non-Patent Citations (4)
| Title |
|---|
| RAMACHANDRAN,R等: "Antihypertensive Potential of Bioactive Hydrolysate from Edible Bird"s Nest", 《AIP CONFERENCE PROCEEDINGS》 * |
| 曹妍等: "印尼白燕窝对免疫低下模型小鼠免疫调节作用的研究", 《营养学报》 * |
| 罗永康: "《生物活性肽功能与制备》", 31 March 2019, 中国轻工业出版社 * |
| 高建萍等: "燕窝低聚肽制备工艺及生物学评价", 《生物学杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111406826A (en) * | 2020-04-30 | 2020-07-14 | 湖北瑞邦生物科技有限公司 | Production method of cubilose peptide product and filtering structure used in production |
| CN113974156A (en) * | 2021-11-23 | 2022-01-28 | 厦门市燕之屋丝浓食品有限公司 | Edible bird's nest oral instant film and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110229857B (en) | 2021-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110257459A (en) | Bird's nest small-molecular peptides and its instant Gly-His-Lys | |
| KR102320465B1 (en) | Walnut oligopeptide powder, manufacturing method and use thereof | |
| WO2020248947A1 (en) | Walnut oligopeptide powder, manufacturing method therefor, and use thereof | |
| CN111019990B (en) | Pumpkin seed peptide powder and preparation method and application thereof | |
| CN102101884A (en) | Preparation method and use of donkey-hide gelatin polypeptide | |
| CN104152521A (en) | Paeonia suffruticosa pollen protein polypeptide and preparation method and application thereof | |
| CN108670979A (en) | Adjust-blood lipid norcholesterol prevents the bear gall powder of cardiovascular and cerebrovascular diseases and atherosclerosis | |
| CN108743621A (en) | The bear gall powder and preparation method of ice crystal state | |
| CN108578433A (en) | For preventing or treating gall stone cholecystitis and improve the bear gall powder of gallbladder function | |
| CN105567771A (en) | Pigskin small peptide chelate and preparation method and application thereof | |
| US10434148B2 (en) | Preparation method of albumin peptide combination having the action of inhibiting the proliferation of cancer cells | |
| CN101647822A (en) | Bionic enzymatic hydrolysate for ground beeltle and application thereof | |
| CN110229857A (en) | The preparation method of bird's nest peptide and its depolymerization coupled enzymatic | |
| CN109601795A (en) | Using penthorum chinense pursh as composition alcohol-decomposing beverage of primary raw material and preparation method thereof | |
| CN108653332A (en) | Inhibition thrombosis and platelet aggregation and the bear gall powder and purposes for preventing cerebral ischemia | |
| CN108546281A (en) | A kind of ginseng oligopeptide and its preparation method and application | |
| CN107648463A (en) | Chinese medicine composition containing oyster peptide with checking exuberance of yang tonifying yin effect and its production and use | |
| CN107488692A (en) | Tool improves polypeptide of osteoporosis effect and its preparation method and application | |
| CN110179128A (en) | Compound enteric-coated capsule of a kind of Chinese fiber crops seed polypeptide and preparation method thereof | |
| CN105907826A (en) | Clean preparation method for plant polypeptide/protein | |
| CN104286844A (en) | Food, health product or medicine composition capable of improving immunity | |
| CN104353057B (en) | Blood-pressure reducing health care product containing european bird cherry anthocyanogen | |
| CN111011854A (en) | Wolfberry extract and preparation method and application thereof | |
| CN105734102B (en) | The preparation method of collagen peptide | |
| CN110272933A (en) | It is a kind of for alleviating the protein peptides and preparation method of dysmenorrhea and female menstrual period discomfort |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |